Blueshift Asset Management, LLC Gritstone Bio, Inc. Transaction History

Blueshift Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$4.03 - $12.19 $63,234 - $191,273	-15,691 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$8.76 - $13.71 $29,565 - $46,271	-3,375 Reduced 17.7%	15,691 $202,000
Q3 2021 Nov 12, 2021	BUY	$6.41 - $13.54 $48,062 - $101,522	7,498 Added 64.82%	19,066 $206,000
Q2 2021 Aug 13, 2021	BUY	$8.13 - $10.2 $94,047 - $117,993	11,568 New	11,568 $106,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.